CN Patent

CN117257922A — 具有低峰-谷比的pth化合物

Assigned to Ascendis Pharma Bone Diseases AS · Expires 2023-12-22 · 2y expired

What this patent protects

本发明涉及包含PTH化合物的药物组合物，其中在皮下施用后，PTH化合物的药代动力学特性在一次注射间隔内表现出小于4的峰‑谷比。

USPTO Abstract

本发明涉及包含PTH化合物的药物组合物，其中在皮下施用后，PTH化合物的药代动力学特性在一次注射间隔内表现出小于4的峰‑谷比。

Drugs covered by this patent

Patent Metadata

Patent number
CN117257922A
Jurisdiction
CN
Classification
—
Expires
2023-12-22
Drug substance claim
No
Drug product claim
No
Assignee
Ascendis Pharma Bone Diseases AS
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.